WALTHAM, Mass.

马萨诸州沃尔瑟姆

,

，

Aug. 6, 2026

2026年8月6日

/PRNewswire/ -- Body Vision Medical, a global leader in AI-powered intraoperative imaging, has closed a new round of funding to capitalize on the rising demand for advanced imaging technology used to support the diagnosis and treatment of early-stage lung diseases. The round was led by Business Asia Consultants, Inc.

/美通社/ -- 全球AI赋能术中成像领域的领导者Body Vision Medical已完成新一轮融资，以把握日益增长的先进成像技术需求，该技术用于支持早期肺部疾病的诊断与治疗。本轮融资由Business Asia Consultants, Inc.领投。

(BAC), a U.S. corporation, and Sprim Global Investments, headquartered in Singapore..

（BAC），一家美国公司，以及总部位于新加坡的Sprim Global Investments。

BAC is an international sales, marketing, and business development consulting firm led by President and CEO Larry Kronick. The company specializes in guiding medical device and healthcare technology firms through market expansion across Asia, Europe, Latin America, and the Middle East.

BAC 是一家国际销售、营销和业务发展咨询公司，由总裁兼首席执行官 Larry Kronick 领导。该公司专注于指导医疗器械和医疗技术公司在亚洲、欧洲、拉丁美洲和中东地区进行市场扩张。

According to Mr. Kronick: 'The global market for Body Vision technology continues to expand exponentially as more countries launch their nationalized lung cancer screening programs. We're positioned to address this demand with a navigation and advanced imaging solution that not only can improve diagnostic yield during biopsy procedures deep in the lung, but we can provide this technology at a very affordable cost.'.

克罗尼克先生表示：“随着越来越多的国家启动国家级肺癌筛查项目，Body Vision技术的全球市场持续呈指数级增长。我们已准备好通过一款导航与先进成像解决方案来满足这一需求，该方案不仅能提高深部肺组织活检过程中的诊断阳性率，还能以极具竞争力的成本提供此项技术。”

Sprim deploys strategic capital into early-stage startups while leveraging its parent network's deep regulatory, clinical, and commercialization expertise to de-risk execution. Gonzalo Rubio, representing Sprim, said: 'We are excited to have this opportunity. Body Vision technology continues to prove its value in the hands of thoracic surgeons and interventional pulmonologists across the globe.

Sprim 向早期初创企业部署战略资本，同时利用其母公司网络在监管、临床和商业化方面的深厚专业知识，以降低执行风险。Sprim 代表 Gonzalo Rubio 表示：“我们很高兴能获得这一机会。Body Vision 的技术在全球胸外科医生和介入肺科医生手中持续证明其价值。”

With access to 46 countries through more than 20 established and highly trained distributors, we see this technology having a significant impact on the early diagnosis and localized treatment of lung cancer and other diseases well into the future.'.

通过20多家成熟且训练有素的经销商，我们的产品已覆盖46个国家。我们相信，这项技术将在未来很长一段时间内对肺癌及其他疾病的早期诊断和局部治疗产生重大影响。

About Body Vision Medical

关于 Body Vision Medical

Body Vision Medical believes in saving lives through the globalization of innovative medical technology. LungVision® provides AI-powered real-time image guidance to address the clinical need for early, definitive lung cancer diagnosis and to enable localized treatment of lung lesions via minimally invasive procedures..

Body Vision Medical 坚信通过创新医疗技术的全球化来拯救生命。LungVision® 提供基于人工智能的实时图像引导，以满足早期、确切诊断肺癌的临床需求，并通过微创手术实现肺部病灶的局部治疗。

Visit

访问

BodyVisionMedical.com

BodyVisionMedical.com

to learn more.

了解更多。

Contact

联系

Mike Hostetler

迈克·霍斯特勒

+1.651.366.9584

+1.651.366.9584

[email protected]

[email protected]

SOURCE Body Vision Medical

来源：Body Vision Medical

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示